Plastic Surgery Doctors in Troy, NY Accepting Medicare

3 Plastic Surgery doctors found. Showing 1 - 3

Dr. Adrian Przybyla, M.D. Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 101 Jordan Rd, Suite 103, Troy, NY 12180 Phone: 518-274-6829    Fax: 518-874-3723

Dr. Marthe A Gabey, M. D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1 Conway Ct, Troy, NY 12180 Phone: 518-271-0327    Fax: 518-271-1554

Dr. Vladimir Joseph Kalas, M.D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 258 Hoosick Street, Suite 105, Troy, NY 12180 Phone: 518-271-0327    Fax: 518-271-1554

News Archive

Viewpoints: Support for HPV vaccinations; Compassion and GOP debates

Imagine that scientists invented a vaccine that was proved to safely prevent cancer. Imagine that it was licensed and recommended in the U.S. for all preadolescent girls and available to boys as well, yet five years later only 11 percent of children were receiving the full course of shots.

90% of overweight children may not be properly diagnosed

Despite recent widespread media attention given to studies that have indicated one-third of American children have a weight problem, a new study shows just one-third of children who are overweight or obese actually receive that diagnosis by a pediatrician.

Study identifies pathway linked to rheumatoid arthritis

Investigators from Hospital for Special Surgery have identified a pathway involved in turning off inflammation that does not work properly in people with inflammatory arthritis. The finding, reported in the April 23 issue of the journal Immunity, could lead to the development of new therapeutic approaches to treating arthritis in the future.

Bristol-Myers Squibb and Tibotec partner to evaluate daclatasvir-TMC435 combination for HCV

Bristol-Myers Squibb Company announced today that it has entered into a clinical collaboration agreement with Tibotec Pharmaceuticals to evaluate the utility of daclatasvir (BMS-790052), Bristol-Myers Squibb's investigational NS5A replication complex inhibitor, in combination with Tibotec Pharmaceuticals' investigational NS3 protease inhibitor, TMC435, for the treatment of chronic hepatitis C virus (HCV).

Study discovers role of Vav1 oncogene in several cancers

Researchers at the Hebrew University of Jerusalem have discovered that Vav1 - an oncogene (cancer-causing gene) found in recent years to be one of the factors in tumorous tissue growth - plays a wider role in several types of cancer than had previously been thought. The discovery has implications for further concentration on targeting this gene in cancer research.

Read more Medical News

› Verified 9 days ago